Archives novartis

by in
Entry Author Date Location
CTI Goes Up, And Down, And Back Up On Phase 3 Myelofibrosis News 03/09/15 Seattle
Arrowhead’s Novartis RNAi Deal: Big Boost or ‘Stale Potato Chips’? 03/09/15 Wisconsin
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” 03/04/15 Boston
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
Find Out “What’s Hot in Boston Biotech” on April 8 02/05/15 Boston
Cancer Drug Developer G1 Therapeutics Closes $33M Series B Round 02/05/15 Raleigh Durham
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Array Biopharma Gets Rights to Second Novartis Cancer Drug 01/23/15 Boulder/Denver
Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within 01/21/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation 01/15/15 San Diego
Qualcomm Ventures Forms Joint Investment Business with Novartis 01/12/15 San Diego
Surface Oncology Raises $35M to Develop Cancer Immunotherapies 01/08/15 Boston
CART + CRISPR = 1st-Of-Its-Kind Biotech Deal From Novartis, Intellia 01/07/15 Boston
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Rethinking Venture Philanthropy After the Kalydeco Windfall 12/22/14 Boston
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
Array and Novartis End Development Deal for Cancer Drug Binimetinib 12/04/14 Boulder/Denver
Page 2 of 15 « previous page · next page »